Stay updated on Advanced Cancers Nivolumab Immuno-therapy Clinical Trial

Sign up to get notified when there's something new on the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Core study information appears unchanged between the screenshots (title, conditions, eligibility criteria, outcomes, and locations). Any observed differences seem limited to cosmetic UI or formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:18:51.000Z thumbnail image
  3. Check
    36 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T15:51:31.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T09:47:16.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Minor release update to v3.0.2 and removal of the Back to Top element; core content and key attributes remain unchanged.
    Difference
    0.2%
    Check dated 2025-09-14T23:37:38.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T20:17:36.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations, as well as new medical topics related to cancer and immunotherapy. Notably, several previous entries related to antineoplastic agents and immune checkpoint inhibitors have been removed.
    Difference
    3%
    Check dated 2025-08-31T12:58:07.000Z thumbnail image

Stay in the know with updates to Advanced Cancers Nivolumab Immuno-therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page.